Some results have been hidden because they may be inaccessible to you.Show inaccessible results
HYMPAVZI™ (marstacimab-hncq) | Once-Weekly Therapy
SponsoredHYMPAVZI™ (marstacimab-hncq): FDA-Approved, Weekly Subcutaneous Injection Therapy. Find Patients Resources Including A Savings Program For Eligible Patients.Types: Patient Support, Safety Information, Sign Up For Updates, Prescribing Information